Bio Essence Corporation
BIOE
$0.18
-$0.07-27.96%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 205.40K | 1.03M | 13.00K | 59.90K | -205.80K |
| Total Depreciation and Amortization | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.80K | 7.10K | 9.40K | 11.60K | 13.80K |
| Change in Net Operating Assets | -622.20K | 204.80K | 164.50K | 96.30K | 165.90K |
| Cash from Operations | -412.00K | 1.24M | 187.00K | 167.80K | -26.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 429.00K | 125.70K | 217.10K | 80.40K | 346.00K |
| Total Debt Repaid | -420.90K | -1.40M | -375.30K | -248.10K | -321.30K |
| Issuance of Common Stock | 440.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 448.10K | -1.27M | -158.20K | -167.80K | 24.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.20K | -28.70K | 28.70K | 0.00 | -1.40K |